Parnax Lab Limited

PARNAXLAB6

INE383L01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-07-16 EDT			5-day change	1st Jan Change
99.5 ^INR	+0.61%		+0.30%	+12.86%

07-05	Parnax Lab Limited Announces Resignation of Baiju M. Shah as CFO	CI
07-05	Parnax Lab Limited Announces Resignation of Prakash M. Shah as Director and Managing Director	CI

Parnax Lab Limited Announces Resignation of Prakash M. Shah as CEO

July 05, 2024 at 09:49 am

Parnax Lab Limited announced Mr. Prakash M. Shah vide his letter dated July 5, 2024 has tendered his resignation as CEO of the Company, with effect from the close of business on July 5, 2024, due to personal and unavoidable circumstances.

Latest news about Parnax Lab Limited

Parnax Lab Limited Announces Resignation of Baiju M. Shah as CFO	07-05	CI
Parnax Lab Limited Announces Resignation of Prakash M. Shah as Director and Managing Director	07-05	CI
Parnax Lab Limited Announces Resignation of Prakash M. Shah as CEO	07-05	CI
Parnax Lab Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-30	CI
Parnax Lab Limited Approves Reconstitution of Committees of Board of Directors	05-30	CI
Parnax Lab Limited Announces Retirement of Vinayak Desai as an Independent Director	03-31	CI
Parnax Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Parnax Lab Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Parnax Lab Limited Appoints Harish S. Panpalia as a Non-Executive Independent Director	23-09-29	CI
Parnax Lab Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Parnax Lab Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
Parnax Lab Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-30	CI
Parnax Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Parnax Lab Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-10	CI
Parnax Lab Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-30	CI
Parnax Lab Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
Parnax Lab Board Allots Over 2 Million Convertible Warrants to Promoters	22-03-24	MT
Parnax Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Parnax Lab Limited announced that it expects to receive INR 45.78375 million in funding	21-12-31	CI
Parnax Lab Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-13	CI
Parnax Lab Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-14	CI
Parnax Lab Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-30	CI
Parnax Lab Limited Approves the Appointment of Preet Vijay Kukreja as Company Secretary and Compliance Officer	21-06-21	CI
Parnax Lab Limited Announces Resignation of Namrata Kambli as Company Secretary and Compliance Officer of the Company	21-05-31	CI
Parnax Lab Limited Announces Demise of Non-Executive Independent Director Manharbhai Navalchand Jhavari	21-03-01	CI

Chart Parnax Lab Limited

Duration

Period

More charts

Company Profile

Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. It is also focused on the trading of pharmaceuticals and medicinal products. The Company operates through dealing in the pharmaceutical formulations segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, highly viscous products, suspensions and others. The Companyâs subsidiary is Naxpar Pharma Private Limited.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
PARNAX LAB LIMITED	+12.86%	13.59M
CSL LIMITED	+7.40%	101B
SAMSUNG BIOLOGICS CO.,LTD.	+8.42%	42.18B
BIOGEN INC.	-13.04%	32.26B
UCB	+80.80%	29.79B
BIOMARIN PHARMACEUTICAL INC.	-10.92%	16.06B
INCYTE CORPORATION	+1.93%	14.45B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-6.77%	12.01B
ALTEOGEN INC.	+177.16%	10.71B
SWEDISH ORPHAN BIOVITRUM AB	+4.12%	8.89B